BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 11275796)

  • 1. Abnormal expression of epidermal growth factor receptor and c-erbB2 in squamous cell carcinoma of the cervix: correlation with human papillomavirus and prognosis.
    Ngan HY; Cheung AN; Liu SS; Cheng DK; Ng TY; Wong LC
    Tumour Biol; 2001; 22(3):176-83. PubMed ID: 11275796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal expression of pan-ras, c-myc and tp53 in squamous cell carcinoma of cervix: correlation with HPV and prognosis.
    Ngan HY; Cheung AN; Liu SS; Cheng DK; Ng TY; Wong LC
    Oncol Rep; 2001; 8(3):557-61. PubMed ID: 11295080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of human papillomavirus infection and activation of PI3K-AKT pathway in cervical clear cell carcinoma.
    Ueno S; Sudo T; Oka N; Wakahashi S; Yamaguchi S; Fujiwara K; Mikami Y; Nishimura R
    Int J Gynecol Cancer; 2013 Jul; 23(6):1084-91. PubMed ID: 23792604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogene alterations in carcinomas of the uterine cervix: overexpression of the epidermal growth factor receptor is associated with poor prognosis.
    Kersemaekers AM; Fleuren GJ; Kenter GG; Van den Broek LJ; Uljee SM; Hermans J; Van de Vijver MJ
    Clin Cancer Res; 1999 Mar; 5(3):577-86. PubMed ID: 10100709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene amplification and immunohistochemical expression of ERBB2 and EGFR in cervical carcinogenesis. Correlation with cell-cycle markers and HPV presence.
    Conesa-Zamora P; Torres-Moreno D; Isaac MA; Pérez-Guillermo M
    Exp Mol Pathol; 2013 Oct; 95(2):151-5. PubMed ID: 23827764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathologic implications of the epidermal growth factor receptor, cyclooxygenase 2 expression, and human papillomavirus status in squamous cell carcinoma of the uterine cervix in the elderly.
    Giordano G; D'Adda T; Dal Bello B; Brigati F; Bersiga A; Campanini N; Berretta R; Rocco A; Merisio C
    Int J Gynecol Cancer; 2011 Feb; 21(2):337-48. PubMed ID: 21270615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of vascular endothelial growth factor in squamous cell carcinomas of the tonsil in relation to human papillomavirus status and epidermal growth factor receptor.
    Fei J; Hong A; Dobbins TA; Jones D; Lee CS; Loo C; Al-Ghamdi M; Harnett GB; Clark J; O'Brien CJ; Rose B
    Ann Surg Oncol; 2009 Oct; 16(10):2908-17. PubMed ID: 19603236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of human papillomavirus (HPV) status and expression of selected markers (HER2/neu, EGFR, VEGF, CD34, p63, p53 and Ki67/MIB-1) on outcome after (chemo-) radiotherapy in patients with squamous cell carcinoma of uterine cervix.
    Vosmik M; Laco J; Sirak I; Beranek M; Hovorkova E; Vosmikova H; Drastikova M; Hodek M; Zoul Z; Odrazka K; Petera J
    Pathol Oncol Res; 2014 Jan; 20(1):131-7. PubMed ID: 23913252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus infection in Egyptian esophageal carcinoma: correlation with p53, p21, mdm2, C-erbB2 and impact on survival.
    Bahnassy AA; Zekri AR; Abdallah S; El-Shehaby AM; Sherif GM
    Pathol Int; 2005 Feb; 55(2):53-62. PubMed ID: 15693850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical assay of p53, cyclin D1, c-erbB2, EGFr and Ki-67 proteins in HPV-positive and HPV-negative cervical cancers.
    Kedzia W; Schmidt M; Frankowski A; Spaczyński M
    Folia Histochem Cytobiol; 2002; 40(1):37-41. PubMed ID: 11885807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the prognostic significance of cathepsin D, epidermal growth factor receptor, and c-erbB-2 in early cervical squamous cell carcinoma. An immunohistochemical study.
    Kristensen GB; Holm R; Abeler VM; Tropé CG
    Cancer; 1996 Aug; 78(3):433-40. PubMed ID: 8697388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene profiling in Pap-cell smears of high-risk human papillomavirus-positive squamous cervical carcinoma.
    Manavi M; Hudelist G; Fink-Retter A; Gschwandtler-Kaulich D; Pischinger K; Czerwenka K
    Gynecol Oncol; 2007 May; 105(2):418-26. PubMed ID: 17306351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-risk human papillomavirus infection and E6 protein expression in lesions of the uterine cervix.
    Pillai MR; Lakshmi S; Sreekala S; Devi TG; Jayaprakash PG; Rajalakshmi TN; Devi CG; Nair MK; Nair MB
    Pathobiology; 1998; 66(5):240-6. PubMed ID: 9732239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased survival in EGFR gene amplified vulvar carcinoma.
    Growdon WB; Boisvert SL; Akhavanfard S; Oliva E; Dias-Santagata DC; Kojiro S; Horowitz NS; Iafrate AJ; Borger DR; Rueda BR
    Gynecol Oncol; 2008 Nov; 111(2):289-97. PubMed ID: 18768215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer.
    Reimers N; Kasper HU; Weissenborn SJ; Stützer H; Preuss SF; Hoffmann TK; Speel EJ; Dienes HP; Pfister HJ; Guntinas-Lichius O; Klussmann JP
    Int J Cancer; 2007 Apr; 120(8):1731-8. PubMed ID: 17236202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human Papillomavirus and Epidermal Growth Factor Receptor in Oral Cavity and Oropharyngeal Squamous Cell Carcinoma: Correlation With Dynamic Contrast-Enhanced MRI Parameters.
    Choi YS; Park M; Kwon HJ; Koh YW; Lee SK; Kim J
    AJR Am J Roentgenol; 2016 Feb; 206(2):408-13. PubMed ID: 26797372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene amplification and protein overexpression of EGFR and ERBB2 in sinonasal squamous cell carcinoma.
    López F; Llorente JL; Oviedo CM; Vivanco B; Marcos CÁ; García-Inclán C; Scola B; Hermsen MA
    Cancer; 2012 Apr; 118(7):1818-26. PubMed ID: 22009799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus DNA and antibodies to human papillomaviruses 16 E2, L2, and E7 peptides as predictors of survival in patients with squamous cell cervical cancer.
    Viladiu P; Bosch FX; Castellsagué X; Muñoz N; Escribà JM; Hamsíkova E; Hofmannova V; Guerrero E; Izquierdo A; Navarro C; Moreo P; Izarzugaza I; Ascunce N; Gili M; Muñoz MT; Tafur L; Shah KV; Vonka V
    J Clin Oncol; 1997 Feb; 15(2):610-9. PubMed ID: 9053484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD44 mediates constitutive type I receptor signaling in cervical carcinoma cells.
    Wobus M; Kuns R; Wolf C; Horn LC; Köhler U; Sheyn I; Werness BA; Sherman LS
    Gynecol Oncol; 2001 Nov; 83(2):227-34. PubMed ID: 11606076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of epidermal growth factor receptor expression and gene expression status in tissue microarray of cervical squamous cell carcinoma].
    Zhou SY; Feng GF; Chen GR; Pan D; Zhang PN; Yang XM; Xia ZL
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):843-6. PubMed ID: 24444562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.